Latest Updates of Key Players in the Heart Transplant Market with Key Developments 2026
| Company | Headquarters | Latest Update |
| Medtronic | South Korea | In October 2025, Medtronic announced novel clinical milestones spanning coronary, renal denervation, and structural heart businesses at TCT 2025. |
| Abbott Laboratories | United States | In August 2025, Abbott recently announced plans to build novel cardiovascular device manufacturing services in Georgia. |
| Janssen Pharmaceuticals | Belgium | It focuses on high-growth markets such as cardiovascular and surgical robotics, stressing an inclusive portfolio of integrated electrophysiology services. |
| Boston Scientific | United States | Boston Scientific has strengthened its portfolio in cardiovascular care through significant acquisitions and, concurrently, faced governing scrutiny regarding some of its heart rhythm tools. |
| Terumo Corporation | Japan | In August 2025, Terumo Corporation announced that it had entered into a definitive agreement with OrganOx Limited, a leading innovator in organ preservation devices, and its shareholders to acquire outstanding shares of OrganOx. |
| Cardinal Health | United States | In June 2025, Cardinal Health announced the U.S. launch of its multi-parameter, single-patient application monitoring cable and lead wire system that allows the continuous monitoring of cardiac activity, blood oxygen level, and temperature with one point of connection. |
Value Chain Analysis
R&D:
- Major research and development (R&D) in heart transplantation occurs in organ preservation and transportation technologies, mechanical circulatory support (MCS) devices, immunosuppression and rejection monitoring, genetic engineering and xenotransplantation, clinical trials, and patient results research.
- Key Players: TransMedics, Inc. and Abbott Laboratories
Manufacturing Processes:
- Major manufacturing processes involve organ preservation, mechanical circulatory support devices, bioartificial organ engineering, and ablation of consumables.
- Key Players: Medtronic plc and Paragonix Technologies, Inc.
Patient Services:
- Patient services in a heart transplant program are comprehensive, covering the entire journey from initial evaluation to long-term post-operative care.
- Key Players: Novartis AG and Astellas Pharma Inc.
Market Forecast 2026-2035
The global heart transplant market size was estimated at USD 13.62 billion in 2025 and is predicted to increase from USD 15.01 billion in 2026 to approximately USD 35.79 billion by 2035, expanding at a CAGR of 10.14% from 2026 to 2035.
Recent Developments in the Heart Transplant Market
- In February 2026, TransMedics Group, Inc., a healthcare technology organization that is renovating organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that the U.S. Food and Drug Administration (FDA) had granted approval of its Investigational Device Exemption (IDE) for the Next-Generation OCS ENHANCE Heart trial.
- In January 2026, Apollo Hospitals, Chennai, continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported transplant programs. The transplant team, with significant national and international experience, has performed 600+ heart and lung transplants and managed over 2,000 transplant patients.
Get free access to a customized sample report of Heart Transplant Market curated to match your business objectives - Download Now
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
